[1]Food and Drug Administration,HHS.List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness[R].Proposed Rules,1998,63(195):54084. [2]李家增,贺石林,王鸿利,等.血栓病学[M].北京:科学出版社,1998:1-4. [3]Treib J,Baron J F,Grauer M T,et al.An international view of hydroxyethyl starches[J].Intensive Care Med,1999,25:258-268. [4]Ruttmann T G,James M F,Aroson I.In vivo investigation into the effects of hemodilution with hydroxythyl starch(200/0.5) and normal saline on coagulation[J].Br J Anaesth,1998,80:612-616. [5]Ruttmann T G,James M F,Finlayson J.Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery[J].Br J Anaesth,2002,89:226-230. [6]Fries D,Streif W,Margreiter Josef,et al.The effects of perioperatively administered crystalloids and colloids on concentrations of molrvular markers of activated coagulation and fibrinolysis[J].Blood Coagulation and Fibinolysis,2004,15:219. [7]马亚群,潘宁玲,潘贤佖,等.明胶溶液和右旋糖酐对血小板膜糖蛋白受体和纤维蛋白原的影响[J].中华麻醉学杂志,2000,20(3):142-144. [8]Innerhofer P,Fries D,argreiter J,et al.The effects of perioperatively administered colloids and crystalloids on primary platelet mediated hemostasis and clot formation[J].Anesth Analg,2002,95:858-865. |